Repository logoGCRIS
  • English
  • Türkçe
  • Русский
Log In
New user? Click here to register. Have you forgotten your password?
Home
Communities
Browse GCRIS
Entities
Overview
GCRIS Guide
  1. Home
  2. Browse by Author

Browsing by Author "Yetut, Ahsen Duygu"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Article
    Citation - Scopus: 1
    Vinorelbine Induced Serpentine Supravenous Hyperpigmentation
    (Türkiye Klinikleri, 2022) Yetut, Ahsen Duygu; Dirican, Ahmet; Çelik, Cumali; Erdogan, Atıke Pınar; Taş, Semra; Ekinci, Ferhat
    Serpentine supravenous hyperpigmentation (SSH) is a rare complexity arising from antineoplastic therapy. Vinorelbine, a\rchemotherapeutic drug that is frequently used for the treatment of breast and lung cancer, contributes to the etiology of SSH. A 54 years old\rmale patient was being treated for lung adenocarcinoma. An intravenous (IV) infusion of vinorelbine was administered in the distal dorsal vein\rof the left forearm. Erythematous hyperpigmentation at the infusion area was observed a week after the administration of the chemotherapeutic\rdrug. The initial symptoms of SSH usually appear between 1 to 15 days post IV administration of a cytotoxic drug, and it spontaneously becomes\rhyperpigmented within 1-3 weeks. However, these local reactions can be prevented by applying IV infusion for a short period (15-30\rmin) along with adequate venous irrigation (75-124 mL) instead of bolus administration. The termination of the drug can also be considered.
Repository logo
Collections
  • Scopus Collection
  • WoS Collection
  • TrDizin Collection
  • PubMed Collection
Entities
  • Research Outputs
  • Organizations
  • Researchers
  • Projects
  • Awards
  • Equipments
  • Events
About
  • Contact
  • GCRIS
  • Research Ecosystems
  • Feedback
  • OAI-PMH

Log in to GCRIS Dashboard

GCRIS Mobile

Download GCRIS Mobile on the App StoreGet GCRIS Mobile on Google Play

Powered by Research Ecosystems

  • Privacy policy
  • End User Agreement
  • Feedback